Sponsor Dossier
Otsuka Australia Pharmaceutical
Sponsor Dossier for Otsuka Australia Pharmaceutical. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
About
Otsuka Australia Pharmaceutical is an Australian Private Company with ABN 20601768754, registered in NSW. The entity is currently active and registered for GST.
Portfolio
Otsuka Australia Pharmaceutical has four brands on the ARTG, with four indexable brands and four brands with Product Information on file. Two brands have at least one PBS-listed item, three brands have PBAC outcome records, and one brand has an AusPAR on record. Notable brands include ABILIFY, BUSULFEX, JINARC, and SAMSCA.
Therapeutic focus
— Neurology: 1 brand — Urology: 1 brand — Endocrinology: 1 brand — Immunology: 1 brand
PBS footprint
Two brands have at least one PBS-listed item in the portfolio. The latest PBS schedule date the portfolio touched was 1 May 2026.
Regulatory activity
The latest PBAC outcome was recorded on 1 December 2024, with three brands holding PBAC outcomes on record. The latest AusPAR was published on 10 March 2017, with one brand holding an AusPAR on record.